Skip to main content
. 2020 Jan 21;30(5):2973–2983. doi: 10.1007/s00330-019-06595-w

Table 2.

The diagnostic performance of TL and non-TL in GM and EM

Stage and method AUC p value Sensitivity (%) Specificity (%) PPV
(%)
NPV
(%)
LR+ LR−
Training cohort
  S4
    GM non-TL 0.957 (0.945–0.968) < .001 91.0 88.4 88.8 89.9 7.2 0.1
    TL 0.994 (0.945–0.968) 95.1 95.6 96.3 95.8 21.3 0.0
    EM non-TL 0.991 (0.983–0.995) .001 96.3 93.9 97.4 96.6 18.6 0.0
    TL 1.0 (0.992–1.0) 100.0 100.0 100.0 100.0 / 0.0
  ≥ S3
    GM non-TL 0.978 (0.966–0.989) .002 92.1 93.1 95.3 88.5 13.3 0.1
    TL 0.992 (0.981–0.997) 96.9 95.0 97.1 95.0 19.0 0.0
    EM non-TL 0.985 (0.977–0.990) .002 96.5 89.1 95.0 92.7 8.7 0.0
    TL 0.993 (0.983–0.998) 97.4 95.8 98.1 97.0 23.4 0.0
  ≥ S2
    GM non-TL 0.985 (0.976–0.991) .001 93.9 95.2 97.58 87.27 19.5 0.1
    TL 0.992 (0.9719–1.0) 95.7 94.4 97.50 95.04 22.3 0.0
    EM non-TL 0.988 (0.981–0.991) .001 92.8 96.9 98.33 84.77 20.9 0.1
    TL 0.994 (0.981–0.998) 98.8 96.0 98.08 97.04 25.8 0.0
Test cohort
  S4
    GM non-TL 0.852 (0.785–0.901) .002 81.6 75.3 79.8 77.5 3.3 0.2
    TL 0.897 (0.831–0.940) 86.0 83.6 87.8 81.3 5.2 0.2
    EM non-TL 0.862 (0.787–0.920) .002 81.1 75.9 82.1 74.5 3.4 0.3
    TL 0.921 (0.897–0.951) 89.1 87.0 92.8 81.3 6.9 0.1
  ≥ S3
    GM non-TL 0.843 (0.768–0.901) .002 80.5 66.7 78.5 72.3 2.4 0.3
    TL 0.885 (0.827–0.919) 87.7 84.3 92.1 76.8 5.6 0.2
    EM non-TL 0.861 (0.785–0.916) .002 83.6 82.5 91.8 76.7 5.1 0.1
    TL 0.910 (0.853–0.952) 85.2 90.0 93.1 73.3 8.1 0.2
  ≥ S2
    GM non-TL 0.844 (0.769–0.902) .001 70.0 74.1 76.2 67.2 2.7 0.4
    TL 0.882 (0.825–0.918) 87.1 83.3 89.9 70.6 5.3 0.1
    EM non-TL 0.867 (0.793–0.917) .003 85.9 81.4 90.1 74.7 4.6 0.2
    TL 0.907 (0.793–0.917) 87.9 83.2 90.2 76.0 5.5 0.2

Data in parentheses are 95% confidence intervals

Non-TL non-transfer learning, TL transfer learning, GM gray scale modality, EM elastogram modality, NPV negative predictive value, PPV positive predictive value, LR+ positive diagnostic likelihood ratio, LR− negative diagnostic likelihood ratio